References
- Katzin WE, Julius CJ, Tubbs RR, McHenry MC. Lymphoproliferative disorders associated with carbamazepine. Arch Pathol Lab Med 1990; 114: 1244–1248
- Severson GS, Harrington DS, Burnett DA, Linder J. Dermatopathic lymphadenopathy associated with carbamazepine: a case mimicking a lymphoid malignancy. Am J Med 1987; 83: 597–599
- Houwerzijl J, Degast GC, Nater JP, Esselink MT, Nieweg HO. Lymphocyte stimulative tests and patch tests in carbamazepine sensitivity. Clin Exp Immunol 1977; 29: 272–277
- Brain C, MacArdle B, Levin S. Idiosyncratic reactions to carbamazepine mimicking viral infection in children. BMJ 1984; 189: 354–354
- Sorrel TC, Forbes IJ. Depression of immune competence by phenytoin and carbamazepine: studies in vivo and in vitro. Clin Exp Immunol 1975; 20: 273–285
- Gennis MA, Vermuri R, Burns EA, Hill JV, Miller MA, Speilberg SP. Familial occurrence of hypersensitivity to phenytoin. Am J Med 1991; 91: 631–634
- Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995; 155: 2285–2290
- Knowles DM. Neoplastic Hematopathology. Williams & Wilkins, Baltimore 1992
- Shuttleworth D, Graham-Brown RAC, Williams AJ, Campbell AC, Sewell H. Pseudolymphoma associated with carbamazepine. Clin Exp Dermatol 1984; 9: 421–423
- Sinnige HAM, Boender CA, Kuypers EW, Ruitenberg HM. Carbamazepine-induced pseudolymphoma and immune dysregulation. J Int Med 1990; 227: 355–358
- Rijlaarsdam U, Scheffer E, Meijer CJL, Kruyswijk RJ, Willemze R. Mycosis fungoides-like lesions associated with phenytoin and carbamazepine therapy. J Am Acad Dermatol 1991; 24: 216–220
- Bitter MA, Franklin WA, Larson RA, McKeithan TW, Rubin CM, Le Beau MM, Stephens JK, Vardiman JW. Morphology in Ki-1 (CD30) non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormalities, t(2;5)(p23;q35). Am J Surg Pathol 1990; 14: 305–316
- Segal GH, Kjeldsberg CR, Smith GP, Perkins SL. CD30 antigen in florid immunoblastic proliferations. Am J Clin Pathol 1994; 102: 292–298